554 reports of this reaction
2.3% of all DIPHENHYDRAMINE HCL reports
#5 most reported adverse reaction
PAIN is the #5 most commonly reported adverse reaction for DIPHENHYDRAMINE HCL, manufactured by Meijer Distribution Inc. There are 554 FDA adverse event reports linking DIPHENHYDRAMINE HCL to PAIN. This represents approximately 2.3% of all 24,504 adverse event reports for this drug.
Patients taking DIPHENHYDRAMINE HCL who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is a less commonly reported adverse event for DIPHENHYDRAMINE HCL, but still significant enough to appear in the safety profile.
In addition to pain, the following adverse reactions have been reported for DIPHENHYDRAMINE HCL:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 554 FDA reports for DIPHENHYDRAMINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 2.3% of all adverse event reports for DIPHENHYDRAMINE HCL, making it a notable side effect.
If you experience pain while taking DIPHENHYDRAMINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.